317 related articles for article (PubMed ID: 33254980)
21. Preparation and biological evaluation of antibody targeted metal-organic framework drug delivery system (TDDS) in Her2 receptor-positive cells.
Chen Q; Zhang XN; Ding GY; Ma YF; Zhou MS; Zhang Y
Talanta; 2024 Mar; 269():125380. PubMed ID: 37995639
[TBL] [Abstract][Full Text] [Related]
22. Rational design of curcumin loaded multifunctional mesoporous silica nanoparticles to enhance the cytotoxicity for targeted and controlled drug release.
Chen C; Sun W; Wang X; Wang Y; Wang P
Mater Sci Eng C Mater Biol Appl; 2018 Apr; 85():88-96. PubMed ID: 29407161
[TBL] [Abstract][Full Text] [Related]
23. Study of pH-Responsive and Polyethylene Glycol-Modified Doxorubicin-Loaded Mesoporous Silica Nanoparticles for Drug Delivery.
Qin Y; Shan X; Han Y; Jin H; Gao Y
J Nanosci Nanotechnol; 2020 Oct; 20(10):5997-6006. PubMed ID: 32384944
[TBL] [Abstract][Full Text] [Related]
24. Fabrication of PNIPAM-chitosan/decatungstoeuropate/silica nanocomposite for thermo/pH dual-stimuli-responsive and luminescent drug delivery system.
Huang N; Wang J; Cheng X; Xu Y; Li W
J Inorg Biochem; 2020 Oct; 211():111216. PubMed ID: 32818709
[TBL] [Abstract][Full Text] [Related]
25. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
26. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells.
Zhao Q; Liu J; Zhu W; Sun C; Di D; Zhang Y; Wang P; Wang Z; Wang S
Acta Biomater; 2015 Sep; 23():147-156. PubMed ID: 25985912
[TBL] [Abstract][Full Text] [Related]
27. Contribution of carboxyl modified chiral mesoporous silica nanoparticles in delivering doxorubicin hydrochloride in vitro: pH-response controlled release, enhanced drug cellular uptake and cytotoxicity.
Li J; Du X; Zheng N; Xu L; Xu J; Li S
Colloids Surf B Biointerfaces; 2016 May; 141():374-381. PubMed ID: 26878288
[TBL] [Abstract][Full Text] [Related]
28. pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo.
Xiao X; Liu Y; Guo M; Fei W; Zheng H; Zhang R; Zhang Y; Wei Y; Zheng G; Li F
J Biomater Appl; 2016 Jul; 31(1):23-35. PubMed ID: 27059495
[TBL] [Abstract][Full Text] [Related]
29. Folate-receptor mediated pH/reduction-responsive biomimetic nanoparticles for dually activated multi-stage anticancer drug delivery.
Wang D; Chen W; Li H; Huang G; Zhou Y; Wang Y; Wan W; You B; Liu Y; Zhang X
Int J Pharm; 2020 Jul; 585():119456. PubMed ID: 32492507
[TBL] [Abstract][Full Text] [Related]
30. Ionic and thermo-switchable polymer-masked mesoporous silica drug-nanocarrier: High drug loading capacity at 10°C and fast drug release completion at 40°C.
Eltohamy M; Seo JW; Hwang JY; Jang WC; Kim HW; Shin US
Colloids Surf B Biointerfaces; 2016 Aug; 144():229-237. PubMed ID: 27092438
[TBL] [Abstract][Full Text] [Related]
31. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y
Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789
[TBL] [Abstract][Full Text] [Related]
32. Thermo/pH dual-stimuli-responsive drug delivery for chemo-/photothermal therapy monitored by cell imaging.
Shu Y; Song R; Zheng A; Huang J; Chen M; Wang J
Talanta; 2018 May; 181():278-285. PubMed ID: 29426513
[TBL] [Abstract][Full Text] [Related]
33. pH-responsive nanoreservoirs based on hyaluronic acid end-capped mesoporous silica nanoparticles for targeted drug delivery.
Chen C; Sun W; Wang X; Wang Y; Wang P
Int J Biol Macromol; 2018 May; 111():1106-1115. PubMed ID: 29357289
[TBL] [Abstract][Full Text] [Related]
34. A dual-targeting Fe
Liu X; Wang C; Wang X; Tian C; Shen Y; Zhu M
Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111455. PubMed ID: 33255040
[TBL] [Abstract][Full Text] [Related]
35. UV-light cross-linked and pH de-cross-linked coumarin-decorated cationic copolymer grafted mesoporous silica nanoparticles for drug and gene co-delivery in vitro.
Zhou S; Ding C; Wang C; Fu J
Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110469. PubMed ID: 31923958
[TBL] [Abstract][Full Text] [Related]
36. A facile strategy to fabricate a pH-responsive mesoporous silica nanoparticle end-capped with amphiphilic peptides by self-assembly.
Zhao F; Zhang C; Zhao C; Gao W; Fan X; Wu G
Colloids Surf B Biointerfaces; 2019 Jul; 179():352-362. PubMed ID: 30991215
[TBL] [Abstract][Full Text] [Related]
37. PEGylated Poly(α-lipoic acid) Loaded with Doxorubicin as a pH and Reduction Dual Responsive Nanomedicine for Breast Cancer Therapy.
Yang H; Shen W; Liu W; Chen L; Zhang P; Xiao C; Chen X
Biomacromolecules; 2018 Nov; 19(11):4492-4503. PubMed ID: 30346147
[TBL] [Abstract][Full Text] [Related]
38. Hollow mesoporous silica nanoparticles facilitated drug delivery via cascade pH stimuli in tumor microenvironment for tumor therapy.
Liu J; Luo Z; Zhang J; Luo T; Zhou J; Zhao X; Cai K
Biomaterials; 2016 Mar; 83():51-65. PubMed ID: 26773665
[TBL] [Abstract][Full Text] [Related]
39. pH and Ultrasound Dual-Responsive Polydopamine-Coated Mesoporous Silica Nanoparticles for Controlled Drug Delivery.
Li X; Xie C; Xia H; Wang Z
Langmuir; 2018 Aug; 34(34):9974-9981. PubMed ID: 30056720
[TBL] [Abstract][Full Text] [Related]
40. Enhanced Cellular Internalization and On-Demand Intracellular Release of Doxorubicin by Stepwise pH-/Reduction-Responsive Nanoparticles.
Li F; Chen WL; You BG; Liu Y; Yang SD; Yuan ZQ; Zhu WJ; Li JZ; Qu CX; Zhou YJ; Zhou XF; Liu C; Zhang XN
ACS Appl Mater Interfaces; 2016 Nov; 8(47):32146-32158. PubMed ID: 27933846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
